Skip to main content
Equibles

GMAB · Genmab A/S · Earnings Call Transcripts & Audio

Track GMAB — free

Use GMAB with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GMAB.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$35.68 +0.11 (+0.30%) At close · Sep 30
Rebalance outlook locked
Market Cap
$21.72B
Shares
614.90M
Volume · Sep 30 5.15M Avg daily vol (3M) 2.39M

Genmab A/S Earnings Call Transcripts

Quarterly earnings calls for Genmab A/S (GMAB), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
· $779.00M $203.00M '24 Q2 24-08-08 ▲18.7% $925.00M $336.00M '25 Q2 25-08-07 LATEST ▲24.9% $1.16B $303.00M '26 Q2 26-08-06
Conference
Investor event
2026-09-22
Genmab A/S (GMAB) September 2026 Conference
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-09-15
Genmab A/S (GMAB) September 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-09-09
Genmab A/S (GMAB) September 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-06
Genmab A/S (GMAB) Q2 2026 Earnings Call
Revenue
$1.16B
▲ 24.9% YoY
Diluted EPS
$4.91
▼ 9.4% YoY
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-07
Genmab A/S (GMAB) Q1 2026 Earnings Call Transcript
Confident tone Pipeline and trial design disclosures Epkinly commercial momentum Rina-S (petosemtamab) pipeline catalysts
Results not yet reported
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-03-11
Genmab A/S (GMAB) March 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2026-02-17
Genmab A/S (GMAB) Q4 2025 Earnings Call Transcript
Confident tone EPKINLY commercial performance and pipeline expansion Petosemtamab (Merus acquisition) late-stage catalysts TIVDAK global commercial launches
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-09-29
Genmab A/S (GMAB) Q3 2025 Earnings Call Transcript
Confident tone Rina-S late-stage development EPKINLY (epcoritamab) commercial and clinical progress Merus acquisition / petosemtamab
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Genmab A/S (GMAB) Q2 2025 Earnings Call Transcript
Confident tone Rina-S pipeline expansion Epcoritamab/EPKINLY in follicular lymphoma Financial performance and capital allocation
Revenue
$925.00M
▲ 18.7% YoY
Diluted EPS
$5.42
▲ 73.2% YoY
Rev · 2q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Genmab A/S (GMAB) Q1 2025 Earnings Call Transcript
Confident tone Rina-S pipeline progress and data EPKINLY commercial performance and expansion Proprietary late-stage pipeline focus
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-12
Genmab A/S (GMAB) Q4 2024 Earnings Call Transcript
Confident tone EPKINLY GEN1042 / INI opportunity Rina-S
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-09-30
Genmab A/S (GMAB) Q3 2024 Earnings Call Transcript
Confident tone Wholly-owned late-stage assets EPKINLY commercial performance EPKINLY pipeline expansion
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Genmab A/S (GMAB) Q2 2024 Earnings Call Transcript
Confident tone acasunlimab development EPKINLY / epcoritamab commercial launch ProfoundBio acquisition / Rina-S
Revenue
$779.00M
Diluted EPS
$3.13
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Genmab A/S (GMAB) Q1 2024 Earnings Call Transcript
Confident tone Epcoritamab/EPKINLY regulatory progress and launch ProfoundBio acquisition and Rina-S ADC pipeline TIVDAK cervical cancer and head & neck expansion
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Genmab A/S (GMAB) Q4 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-09-30
Genmab A/S (GMAB) Q3 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
Genmab A/S (GMAB) Q2 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
Genmab A/S (GMAB) Q1 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Genmab A/S (GMAB) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-09-30
Genmab A/S (GMAB) Q3 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
Genmab A/S (GMAB) Q2 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
Genmab A/S (GMAB) Q1 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-12-31
Genmab A/S (GMAB) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-09-30
Genmab A/S (GMAB) Q3 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-06-30
Genmab A/S (GMAB) Q2 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-03-31
Genmab A/S (GMAB) Q1 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-12-31
Genmab A/S (GMAB) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-09-30
Genmab A/S (GMAB) Q3 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-06-30
Genmab A/S (GMAB) Q2 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-03-31
Genmab A/S (GMAB) Q1 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–30 of 30 earnings calls
Key facts CIK 1434265 CUSIP 372303206 13F (30d) 7 filings 7 filers Visit website Investor relations